Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
49.7M
-
Number of holders
-
554
-
Total 13F shares, excl. options
-
44.6M
-
Shares change
-
+1.52M
-
Total reported value, excl. options
-
$8.79B
-
Value change
-
+$296M
-
Put/Call ratio
-
0.47
-
Number of buys
-
282
-
Number of sells
-
-287
-
Price
-
$196.80
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q3 2022
677 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q3 2022.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 554 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.6M shares
of 49.7M outstanding shares and own 89.89% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.98M shares), STATE STREET CORP (2.03M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.63M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.59M shares), Clearbridge Investments, LLC (1.45M shares), Invesco Ltd. (1.03M shares), GEODE CAPITAL MANAGEMENT, LLC (995K shares), Allspring Global Investments Holdings, LLC (976K shares), Jackson Square Partners, LLC (871K shares), and FMR LLC (740K shares).
This table shows the top 554 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.